GUIDE Co-Chair

Dr. Emilie Belley-Côté

Bio

Dr. Belley-Côté obtained her MD from Université de Sherbrooke. After internal medicine and cardiology training, as well as an MSc in Clinical Sciences (research profile) at Université de Sherbrooke, she completed a critical care fellowship at McMaster University, as well as the Clinician Investigator Program and PhD in Clinical Epidemiology.

Academic Interests

Her primary research focus is to improve the short and long-term outcomes of patients undergoing cardiac surgery.

• The ATLAS Trial: A Look Before We LeAAPS
  November 14, 2022
• Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis
  October 18, 2022
• Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
  October 13, 2022
• Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
  October 13, 2022
• Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis
  October 4, 2022
• Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study
  September 19, 2022
• Prolonged mechanical ventilation after cardiac surgery: substudy of the Transfusion Requirements in Cardiac Surgery III trial
  September 19, 2022
• The Syncopal Sarcoma: A Rare Case of Primary Cardiac Synovial Sarcoma
  September 5, 2022
• A survey of cardiac surgeons to evaluate the use of sutureless aortic valve replacement in Canada
  August 23, 2022
• What is the optimal prosthetic valve in dialysis?
  July 22, 2022